Annual recurring revenue (ARR) increased 5% year over year to $499 million.
Cash from operations was $34 million (28% of revenue) and free cash flow was $30 million (24% of revenue).
Dollar-based net retention rate (DBNR) was 102%, impacted by elevated churn and downgrades due to seat optimization.
GAAP profitability achieved for the first time in company history with a 25% non-GAAP operating margin, exceeding guidance and expanding 800 basis points year over year.
Gross margin was 86%, at the high end of the 84%-86% target range.
International revenue grew 12% year over year, representing 29% of total revenue.
Operating income was $31 million or 25% of revenue, up from $20 million or 17% last year.
Q2 revenue was $123 million, up 6% year over year.
DRAM revenue for fiscal 2025 was a record $28.6 billion, up 62% year over year; fiscal Q4 DRAM revenue was $9 billion, up 69% year over year and 27% sequentially.
EPS for fiscal 2025 reached $8.29, a 538% increase year over year; fiscal Q4 non-GAAP EPS was $3.03, up 157% year over year and 59% sequentially.
Fiscal 2025 revenue grew nearly 50% to a record $37.4 billion, with fiscal Q4 revenue at $11.3 billion, up 46% year over year and 22% sequentially.
Free cash flow for fiscal 2025 was $3.7 billion, representing 10% of revenue; fiscal Q4 free cash flow was $803 million.
Gross margins expanded by 17 percentage points to 41% for fiscal 2025, with fiscal Q4 gross margin at 45.7%, up 670 basis points sequentially.
NAND revenue for fiscal 2025 was a record $8.5 billion, up 18% year over year; fiscal Q4 NAND revenue was $2.3 billion, down 5% year over year but up 5% sequentially.
Operating expenses in fiscal Q4 were $1.2 billion, up $81 million sequentially, driven primarily by higher R&D.
Operating income in fiscal Q4 was $4 billion, with an operating margin of 35%, up 820 basis points sequentially and 12 percentage points year over year.